BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3385033)

  • 1. Cyclosporin a (cyclosporine) in the treatment of cutaneous T cell lymphoma (mycosis fungoides).
    Kreis W; Budman DR; Shapiro PE
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1138-40. PubMed ID: 3385033
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cutaneous T cell lymphoma with cyclosporin A.
    Moreland AA; Robertson DB; Heffner LT
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):886-7. PubMed ID: 3874214
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine in the treatment of cutaneous T cell lymphoma.
    Street ML; Muller SA; Pittelkow MR
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1084-9. PubMed ID: 2273106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A therapy for mycosis fungoides.
    Jensen JR; Thestrup-Pedersen K; Zachariae H; Søgaard H
    Arch Dermatol; 1987 Feb; 123(2):160-3. PubMed ID: 3813585
    [No Abstract]   [Full Text] [Related]  

  • 5. Remission in skin infiltrate of a patient with mycosis fungoides treated with cyclosporine.
    Maddox AM; Kahan BD; Tucker S; Kerman R; Jordan RE
    J Am Acad Dermatol; 1985 May; 12(5 Pt 2):952-6. PubMed ID: 3158679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracutaneous spreading with fatal outcome of mycosis fungoides in a patient treated with ciclosporin A: a word of caution.
    Thomsen K; Wantzin GL
    Dermatologica; 1987; 174(5):236-8. PubMed ID: 3582709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of activated T lymphocytes in mycosis fungoides.
    Wehrmann W; Bauer R; Fuchs D; Hausen A; Reibnegger G; Werner ER; Wachter H
    Eur J Clin Microbiol; 1987 Apr; 6(2):210-1. PubMed ID: 3496216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid.
    Kessler JF; Meyskens FL; Levine N; Lynch PJ; Jones SE
    Lancet; 1983 Jun; 1(8338):1345-7. PubMed ID: 6134133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Update: Update on Cutaneous and Systemic Therapy for Primary Cutaneous T Cell Lymphoma, Mycosis Fungoides.
    Lo Sicco K; Latkowski JA
    J Drugs Dermatol; 2015 Dec; 14(12):1381-3. PubMed ID: 26659928
    [No Abstract]   [Full Text] [Related]  

  • 10. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
    Van Scott EJ; Grekin DA; Kalmanson JD; Vonderheid EC; Barry WE
    Cancer; 1975 Nov; 36(5):1613-8. PubMed ID: 1192353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
    Shelley WB
    Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of childhood mycosis fungoides with topical PUVA.
    Pabsch H; Rütten A; Von Stemm A; Meigel W; Sander CA; Schaller J
    J Am Acad Dermatol; 2002 Oct; 47(4):557-61. PubMed ID: 12271301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy.
    Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cutaneous T-cell lymphoma with the arotinoid Ro 13-6298.
    Tousignant J; Raymond GP; Light MJ
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 2):167-71. PubMed ID: 3493269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides d'emblée: a rare presentation of cutaneous T-cell lymphoma.
    Blasik LG; Newkirk RE; Dimond RL; Clendenning WE
    Cancer; 1982 Feb; 49(4):742-7. PubMed ID: 6976825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
    J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poikilodermatous mycosis fungoides.
    Farley-Loftus R; Mandal R; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
    Coors EA; Schuler G; Von Den Driesch P
    Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.